These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19210755)

  • 1. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.
    García-Castro J; Trigueros C; Madrenas J; Pérez-Simón JA; Rodriguez R; Menendez P
    J Cell Mol Med; 2008 Dec; 12(6B):2552-65. PubMed ID: 19210755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation.
    English K; Mahon BP; Wood KJ
    Curr Drug Deliv; 2014; 11(5):561-71. PubMed ID: 23517624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.
    Kot M; Baj-Krzyworzeka M; Szatanek R; Musiał-Wysocka A; Suda-Szczurek M; Majka M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive properties of mesenchymal stem cells.
    Abumaree M; Al Jumah M; Pace RA; Kalionis B
    Stem Cell Rev Rep; 2012 Jun; 8(2):375-92. PubMed ID: 21892603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?
    Lohan P; Coleman CM; Murphy JM; Griffin MD; Ritter T; Ryan AE
    Stem Cell Res Ther; 2014 Aug; 5(4):99. PubMed ID: 25158057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
    Caplan AI
    J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
    Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE
    Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells: immune evasive, not immune privileged.
    Ankrum JA; Ong JF; Karp JM
    Nat Biotechnol; 2014 Mar; 32(3):252-60. PubMed ID: 24561556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
    Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
    Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells.
    Sherman LS; Munoz J; Patel SA; Dave MA; Paige I; Rameshwar P
    Clin Transl Sci; 2011 Oct; 4(5):380-6. PubMed ID: 22029813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory activity of mesenchymal stem cells.
    Kaplan JM; Youd ME; Lodie TA
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):297-316. PubMed ID: 21190531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.